-
Something wrong with this record ?
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland
S. Piscuoglio, N. Fusco, CK. Ng, LG. Martelotto, A. da Cruz Paula, N. Katabi, BP. Rubin, A. Skálová, I. Weinreb, B. Weigelt, JS. Reis-Filho,
Language English Country Great Britain
Document type Journal Article
PubMed
26426580
DOI
10.1111/his.12883
Knihovny.cz E-resources
- MeSH
- Adenocarcinoma diagnosis enzymology genetics pathology MeSH
- Adult MeSH
- Genotype MeSH
- Gene Rearrangement MeSH
- Middle Aged MeSH
- Humans MeSH
- Microdissection MeSH
- Mutation MeSH
- Salivary Gland Neoplasms diagnosis enzymology genetics pathology MeSH
- Protein Kinase C genetics MeSH
- Protein Domains MeSH
- Amino Acid Sequence MeSH
- Sequence Analysis, DNA MeSH
- Sequence Alignment MeSH
- Aged MeSH
- Salivary Glands pathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
AIMS: Polymorphous low-grade adenocarcinoma (PLGA) is the second most common intra-oral salivary gland malignancy. The vast majority of PLGAs harbour a PRKD1 E710D hot-spot somatic mutation or somatic rearrangements of PRKD1, PRKD2 or PRKD3. Given the kinase domain homology among PRKD1, PRKD2 and PRKD3, we sought to define whether PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements would be driven by somatic mutations affecting the kinase domains of PRKD2 or PRKD3. METHODS AND RESULTS: DNA was extracted from eight microdissected PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements. Samples were thoroughly centrally reviewed, microdissected and subjected to Sanger sequencing of the kinase domains of the PRKD2 and PRKD3 genes. None of the PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 or PRKD3 genes. CONCLUSION: PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements are unlikely to harbour somatic mutations in the kinase domains of PRKD2 or PRKD3. Further studies are warranted to define the driver genetic events in this subgroup of PLGAs.
Department of Pathology Medical Faculty of Charles University Plzen Czech Republic
Department of Pathology Memorial Sloan Kettering Cancer Center New York NY USA
Department of Pathology University Health Network Toronto Ontario Canada
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017394
- 003
- CZ-PrNML
- 005
- 20180516140248.0
- 007
- ta
- 008
- 180515s2016 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/his.12883 $2 doi
- 035 __
- $a (PubMed)26426580
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Piscuoglio, Salvatore $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 245 10
- $a Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland / $c S. Piscuoglio, N. Fusco, CK. Ng, LG. Martelotto, A. da Cruz Paula, N. Katabi, BP. Rubin, A. Skálová, I. Weinreb, B. Weigelt, JS. Reis-Filho,
- 520 9_
- $a AIMS: Polymorphous low-grade adenocarcinoma (PLGA) is the second most common intra-oral salivary gland malignancy. The vast majority of PLGAs harbour a PRKD1 E710D hot-spot somatic mutation or somatic rearrangements of PRKD1, PRKD2 or PRKD3. Given the kinase domain homology among PRKD1, PRKD2 and PRKD3, we sought to define whether PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements would be driven by somatic mutations affecting the kinase domains of PRKD2 or PRKD3. METHODS AND RESULTS: DNA was extracted from eight microdissected PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements. Samples were thoroughly centrally reviewed, microdissected and subjected to Sanger sequencing of the kinase domains of the PRKD2 and PRKD3 genes. None of the PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 or PRKD3 genes. CONCLUSION: PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements are unlikely to harbour somatic mutations in the kinase domains of PRKD2 or PRKD3. Further studies are warranted to define the driver genetic events in this subgroup of PLGAs.
- 650 _2
- $a adenokarcinom $x diagnóza $x enzymologie $x genetika $x patologie $7 D000230
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genová přestavba $7 D015321
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrodisekce $7 D042282
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a proteinkinasa C $x genetika $7 D011493
- 650 _2
- $a nádory slinných žláz $x diagnóza $x enzymologie $x genetika $x patologie $7 D012468
- 650 _2
- $a slinné žlázy $x patologie $7 D012469
- 650 _2
- $a sekvenční seřazení $7 D016415
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fusco, Nicola $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
- 700 1_
- $a Ng, Charlotte K Y $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Martelotto, Luciano G $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a da Cruz Paula, Arnaud $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Instituto Português de Oncologia, Oporto, Portugal.
- 700 1_
- $a Katabi, Nora $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Rubin, Brian P $u Department of Pathology, Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
- 700 1_
- $a Skálová, Alena $u Department of Pathology, Medical Faculty of Charles University, Plzen, Czech Republic.
- 700 1_
- $a Weinreb, Ilan $u Department of Pathology, University Health Network, Toronto, Ontario, Canada.
- 700 1_
- $a Weigelt, Britta $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Reis-Filho, Jorge S $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 773 0_
- $w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 68, č. 7 (2016), s. 1055-62
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26426580 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180516140424 $b ABA008
- 999 __
- $a ok $b bmc $g 1301018 $s 1014234
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 68 $c 7 $d 1055-62 $e 20160104 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
- LZP __
- $a Pubmed-20180515